Clinical trial NCT04212468: Home Blood Pressure Monitoring Registration Study in the Elderly(HOME Study)
Official title: Home Blood Pressure Registration Study on Community Elderly Population(HOME Study)
Study type: OBSERVATIONAL
Overall status: RECRUITING
Conditions: Blood Pressure
Keywords: Blood Pressure
Elderly
Lead sponsor: Guangdong Provincial People's Hospital
Sponsor class: OTHER
First posted: 2019-12-27
Enrollment: 6000
Sex: ALL
Minimum age (years): 65
Standard ages: OLDER_ADULT
Accepts healthy volunteers: yes
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Study population includes subjects who living in community, of any race or ethnicity, 65 or older years of age.

Brief summary: China is entering an aging society. As the number of elderly population continues to increase, the elderly are facing many social problems that deserve the attention of all sectors of society. Hypertension is one of the common diseases in the elderly population. Hypertension is the most common chronic diseases and a most important risk factor for cardiovascular and cerebrovascular diseases, and also a substantial public health problem. Home blood pressure monitoring is simple, not only can find hypertension, but also can guide the treatment of patients with hypertension. The purpose of the study is to investigate the association between home blood pressure and adverse outcomes in community elderly population.

Detailed description: Study population includes subjects who living in community, of any race or ethnicity, 65 or older years of age, and have provided written informed consent to provide home blood pressure monitoring at one or more study visits.

Physical examination, questionnaire survey and biological sample collection will be conducted at baseline and the incidence of a composite of major adverse cardiovascular events will be investigated during follow-up.

Eligibility criteria: Inclusion Criteria:

•≥65 years old

* Signed informed consent
* Life expectancy is greater than 1 year

Exclusion Criteria:

* \<65 years old
* Unsigned informed consent

Primary outcomes:
measure: All-Cause Mortality
timeFrame: From date of inclusion until the date of death from any cause, assessed up to 1 year
measure: Cardiovascular Mortality
timeFrame: From date of inclusion until the date of death from any cause, assessed up to 1 year
Secondary outcomes:
measure: Secondary outcomes of cardiovascular diseases
timeFrame: Through study completion, an average of 1 years
measure: Secondary outcomes of cerebrovascular diseases
timeFrame: Through study completion, an average of 1 years
measure: Secondary outcomes of kidney
timeFrame: Through study completion, an average of 1 years
measure: Secondary outcomes of hypertension
timeFrame: Through study completion, an average of 1 years
measure: Secondary outcomes of diabetes
timeFrame: Through study completion, an average of 1 years
Other outcomes:
measure: Number of participants with reported hospitalization due to other diseases
timeFrame: From date of inclusion until the date of first event, assessed up to 1 year
Locations:
city: Guangzhou
country: China
facility: Feng Yingqing
state: Guangdong
city: Guangzhou
country: China
facility: Guangdong Provincial People's Hospital
state: Guangdong
Study officials:
affiliation: Guangdong Provincial People's Hospital
name: Feng Ying-qing, PhD
role: STUDY_CHAIR
References: